CSIMarket
 


Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's EPS from Cont. Operations Growth by Quarter and Year

Abbott Laboratories's EPS from Cont. Operations results by quarter and year




ABT EPS from Cont. Operations (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 1.22 0.59 0.37
III Quarter September - 0.69 0.54 0.31
II Quarter June - 0.30 0.57 0.41
I Quarter March 1.00 0.31 0.38 0.23
FY   1.00 2.52 2.08 1.32



ABT EPS from Cont. Operations first quarter 2021 Y/Y Growth Comment
Abbott Laboratories achieved in the first quarter, above Company average EPS from Cont. Operations surge of 222.58% year on year, to $ 1.00 .

Looking into first quarter results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher EPS from Cont. Operations growth. While Abbott Laboratories' s EPS from Cont. Operations doubling of 222.58% ranks overall at the positon no. 273 in the first quarter.




ABT EPS from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 106.78 % 59.46 % -
III Quarter September - 27.78 % 74.19 % -3.13 %
II Quarter June - -47.37 % 39.02 % 173.33 %
I Quarter March 222.58 % -18.42 % 65.22 % 4.55 %
FY   - 21.15 % 57.58 % 594.74 %

Financial Statements
Abbott Laboratories's first quarter 2021 EPS from Cont. Operations $ 1.00 ABT's Income Statement
Abbott Laboratories's first quarter 2020 EPS from Cont. Operations $ 0.31 Quarterly ABT's Income Statement
New: More ABT's historic EPS from Cont. Operations Growth >>


ABT EPS from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 76.81 % 9.26 % 19.35 %
III Quarter September - 130 % -5.26 % -24.39 %
II Quarter June - -3.23 % 50 % 78.26 %
I Quarter March -18.03 % -47.46 % 2.7 % -
FY (Year on Year)   - 21.15 % 57.58 % 594.74 %




EPS from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #16
Overall #273

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
193.33 % 5.28 % -84.17 %
(Dec 31 2018)   (Dec 31 2017)
EPS from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #16
Overall #273
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
193.33 % 5.28 % -84.17 %
(Dec 31 2018)   (Dec 31 2017)

EPS from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Abbott Laboratories's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
900 % 32.09 % -91.3 %
(Jun 30 2016)  


ABT's I. Quarter Q/Q EPS from Cont. Operations Comment
In the I. Quarter 2021 Abbott Laboratories disclosed fall in EPS from Cont. Operations from the forth quarter by -18.03% to $ 1.00 , from $ 1.22 released in the previous quarter.

When you look into recent shortcoming in the I. Quarter 2021, you must take into consideration, that commonly I. Quarter performance emerge softer relative to the preciding period, Samuele Agnelli, a business advisor mentioned.

Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Abbott Laboratories's EPS from Cont. Operations growth quarter on quarter, overall rank is 705.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #47
Overall #705
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #47
Overall #705
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
900 % 32.09 % -91.3 %
(Jun 30 2016)  


ABT's I. Quarter Q/Q EPS from Cont. Operations Comment
In the I. Quarter 2021 Abbott Laboratories realized fall in EPS from Cont. Operations from the previous quarter by -18.03% to $ 1.00 , from $ 1.22 achived a quarter before.

As we evaluate present downturn in the I. Quarter 2021, we suppose to take into consideration, that frequently I. Quarter EPS from Cont. Operations emerge weaker relative to the forth quarter, Samuele Agnelli, a business advisor mentioned.

Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Abbott Laboratories's EPS from Cont. Operations growth quarter on quarter, overall rank is 705.


Abbott Laboratories's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative EPS from Cont. Operations 12 Months Ending $ 3.21 $ 2.52 $ 1.89 $ 1.74 $ 2.01
Y / Y EPS from Cont. Operations Growth (TTM) 59.32 % 20.85 % 1.79 % 6.95 % 36.95 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 196 # 473 # 755 # 334 # 301
Seqeuential EPS from Cont. Operations Change (TTM) 27.41 % 32.98 % 8.6 % -13.41 % -3.36 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 273 # 290 # 644 # 681 # 206




Cumulative EPS from Cont. Operations growth Comment
Abbott Laboratories saw improvement in EPS from Cont. Operations growth trend, posting cumulative 12 months EPS from Cont. Operations growth of 59.32% year on year, to $ 3 if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months EPS from Cont. Operations growth was higher than company's average 30.12% and higher than 20.85% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 rise was beneth at 27.41 % from $2.52 achieved in the period from Dec 31 2020 to Mar 31 2020.
In spite of, it was validation of positive momentum, while the typical Q/Q TTM growth lays at 5.28%.
The growth was much higher sequentially showed at 27.41 % jump from $2.52 in twelve months ending a quarter Dec 31 2020.

Among companies within the Healthcare sector 13 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 196, from total ranking in previous quarter at 473.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
193.33 %
5.28 %
-84.17 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 14
Overall # 196

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
635 %
30.12 %
-77.53 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 16
S&P 500 # 273
Cumulative EPS from Cont. Operations growth Comment
Abbott Laboratories saw improvement in EPS from Cont. Operations growth trend, posting cumulative 12 months EPS from Cont. Operations growth of 59.32% year on year, to $ 3 if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months EPS from Cont. Operations growth was higher than company's average 30.12% and higher than 20.85% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 rise was beneth at 27.41 % from $2.52 reported in the period from Dec 31 2020 to Mar 31 2020.
Yet it was validation of strength, as the usual Q/Q TTM EPS from Cont. Operations growth is at 5.28%.
The growth was much more impressive sequentially clinched at 27.41 % increase from $2.52 in twelve months ending a quarter Dec 31 2020.

Among companies within the Healthcare sector 13 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 196, from total ranking in previous quarter at 473.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
193.33 %
5.28 %
-84.17 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 14
Overall # 196

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
635 %
30.12 %
-77.53 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 16
S&P 500 # 273




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
ABT's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for ABT's Competitors
EPS from Cont. Operations Growth for Abbott Laboratories's Suppliers
EPS from Cont. Operations Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar EPS from Cont. Operations fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2021
Quest Diagnostics Inc375.68%$ 375.676 
Quidel Corporation336.46%$ 336.458 
Progyny Inc 240.00%$ 240.000 
Abbott Laboratories222.58%$ 222.581 
Repligen Corp184.21%$ 184.211 
Apollo Medical Holdings Inc 181.82%$ 181.818 
Meridian Bioscience Inc 177.27%$ 177.273 
Iqvia Holdings Inc 158.14%$ 158.140 
Reynolds Consumer Products Inc 150.00%$ 150.000 
Hca Healthcare Inc 144.77%$ 144.767 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CORR's Profile

Stock Price

CORR's Financials

Business Description

Fundamentals

Charts & Quotes

CORR's News

Suppliers

CORR's Competitors

Customers & Markets

Economic Indicators

CORR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071